• 1.

    Gansevoort RT, Hilbrands LB. CKD is a key risk factor for COVID-19 mortality. Nat Rev Nephrol 2020; 16:705706. doi: 10.1038/s41581-020-00349-4

    • Search Google Scholar
    • Export Citation
  • 2.

    Ng JH, et al.. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19 [published online ahead of print August 15, 2020]. Kidney Int doi: 10.1016/j.kint.2020.07.030; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428720/

    • Search Google Scholar
    • Export Citation
  • 3.

    Cozzolino M, et al.. The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management? J Nephrol 2020; 33:629631. doi: 10.1007/s40620-020-00784-3

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Soler MJ, et al.. Impact of the COVID-19 pandemic on Spanish nephrology services. Nefrologia 2020; 40:579584. doi: 10.1016/j.nefro.2020.08.002

Nephrology in Europe in 2021: Modifying the Programs for Home-Based Dialysis and Telemedicine in Nephrology

  • 1 Maria Jose Soler Romeo, MD, PhD, is a nephrologist at Vall d’Hebron University Hospital Campus, Barcelona, Spain.
Restricted access
Save